Tag Archives: The Stem Cell Blog

ImmunoCellular Plans Job Cuts in Shift to Stem-to-T-Cell Program – Genetic Engineering & Biotechnology News (press release)

Continue reading

2017-08-24 NEWS

The Herald of Finance

ImmunoCellular Plans Job Cuts in Shift to Stem-to-TCell Program
Genetic Engineering & Biotechnology News (press release)
The company says that Stem-to-TCell offers a more gradual and measured release of killer T cells than chimeric antigen receptor Tcell (CAR-T) technologies, thus avoiding the limited response, and even toxicity, associated with some CAR-T treatments.
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future StrategyPR Newswire (press release)

all 33 news articles »

Continue reading

2017-08-24 NEWS

Huntington’s Disease News

New CRISPR-Cas9 Technique Corrects Defects Linked to Huntington’s, UCSD Study Suggests
Huntington’s Disease News
CRISPR-Cas9 is an innovative technique designed to edit genes. The process introduces breaks in the DNA of the gene of interest, which would disable the incorrect gene. CRISPR-Cas9 can also be used to replace an incorrect gene with the correct version.
Synbio Technologies Makes Breakthrough in sgRNA LibrariesMENAFN.COM

all 2 news articles »

Continue reading

2017-08-24 NEWS

Huntington’s Disease News

New CRISPR-Cas9 Technique Corrects Defects Linked to Huntington’s, UCSD Study Suggests
Huntington’s Disease News
CRISPR-Cas9 is an innovative technique designed to edit genes. The process introduces breaks in the DNA of the gene of interest, which would disable the incorrect gene. CRISPR-Cas9 can also be used to replace an incorrect gene with the correct version.
Synbio Technologies Makes Breakthrough in sgRNA LibrariesMENAFN.COM

all 2 news articles »

Continue reading

2017-08-24 NEWS

Christian Post

Cancer Cure News 2017: Breakthrough Cancer Drug Could Prove Costly for Patients
Christian Post
The treatment, CTL019, is among a new class of medications called CAR T-cell therapies. This involves harvesting the patient’s white blood cells and genetically altering them to kill cancer. It has been tested on leukemia patients whose cancer relapsed

and more »